LambdaVision, Inc.

LambdaVision is developing the first protein-based artificial retina to restore vision for patients who are blind or have lost significant sight due to advanced retinal degenerative diseases. The company leverages space-based manufacturing to create devices that mimic the light-absorbing properties of human photoreceptors, replacing damaged cells in patients with retinitis pigmentosa and age-related macular degeneration.